VCYT
Veracyte, Inc.
Stock
$45.81+1.62 (+3.67%)Close Oct 2, 2026
Balance sheet
| Line | Q2 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and short-term investments | $300M | $413M | $289M | $217M | $179M | $173M | $349M | $159M | $78M | $34M | $59M | $39M | $35M | $71M | $14M | $7.6M |
| Inventory | — | $21M | $22M | $16M | $14M | $11M | $4.7M | $6.8M | $3.4M | $5.3M | $3.5M | $3.8M | $3.7M | $2.6M | $1.1M | — |
| Current assets | $575M | $488M | $372M | $286M | $249M | $243M | $376M | $188M | $97M | $54M | $74M | $48M | $43M | $76M | $16M | — |
| Goodwill | $767M | $767M | $746M | $703M | $696M | $708M | $2.7M | $2.7M | $1.1M | $1.1M | $1.1M | $1.1M | $1.1M | — | — | — |
| Intangible assets | $83M | $89M | $102M | $89M | $175M | $203M | $60M | $65M | $12M | $13M | $14M | $15M | — | — | — | — |
| Total assets | $1.5B | $1.4B | $1.3B | $1.1B | $1.2B | $1.2B | $457M | $275M | $121M | $79M | $101M | $75M | $65M | $80M | $19M | — |
| Current liabilities | $63M | $60M | $79M | $61M | $63M | $64M | $17M | $17M | $13M | $12M | $12M | $15M | $17M | $15M | $9.0M | — |
| Long-term debt | — | — | — | — | — | $0 | $810K | $694K | $24M | $25M | $25M | $5.0M | $4.9M | $4.9M | — | — |
| Total liabilities | $98M | $96M | $124M | $71M | $81M | $91M | $36M | $36M | $41M | $41M | $41M | $24M | $23M | $23M | $14M | — |
| Shareholders' equity | $1.4B | $1.3B | $1.2B | $1.0B | $1.1B | $1.1B | $421M | $239M | $80M | $37M | $60M | $51M | $41M | $56M | −$58M | −$41M |
| Shares outstanding | 80.4M | 79.5M | 77.9M | 75.1M | 72.1M | 71.2M | 67.0M | 49.7M | 41.1M | 34.3M | 33.8M | 27.9M | 22.6M | 21.1M | — | — |
| Current ratio | 9.16 | 8.15 | 4.73 | 4.66 | 3.97 | 3.79 | 22.39 | 10.74 | 7.42 | 4.48 | 6.38 | 3.25 | 2.53 | 4.97 | 1.82 | — |